The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1)

scientific article published on 04 October 2013

The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBRC.2013.09.107
P698PubMed publication ID24099776

P50authorRodolphe FischmeisterQ40388856
P2093author name stringFrank Lezoualc'h
Pascal Bouyssou
Jean-Paul Blondeau
Delphine Courilleau
P433issue3
P921main subjectenantiomerQ494483
P304page(s)443-448
P577publication date2013-10-04
P1433published inBiochemical and Biophysical Research CommunicationsQ864228
P1476titleThe (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1)
P478volume440

Reverse relations

cites work (P2860)
Q36866394A cardiac mitochondrial cAMP signaling pathway regulates calcium accumulation, permeability transition and cell death
Q37338829Calcium/calmodulin-dependent kinase II and nitric oxide synthase 1-dependent modulation of ryanodine receptors during β-adrenergic stimulation is restricted to the dyadic cleft
Q26781612Cardiac cAMP: production, hydrolysis, modulation and detection
Q38781876Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation
Q28608179Exchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: Structure, function and therapeutics
Q38747476Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets
Q37653245Identification and validation of modulators of exchange protein activated by cAMP (Epac) activity: structure-function implications for Epac activation and inhibition
Q52656382Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.
Q48323009Microtubule-regulating proteins and cAMP-dependent signaling in neuroblastoma differentiation
Q85666404Proarrhythmic effect of sustained EPAC activation on TRPC3/4 in rat ventricular cardiomyocytes
Q30405298Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).
Q36624204Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists
Q49497128Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors.
Q47443813Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs).
Q21145700Structure-guided design of selective Epac1 and Epac2 agonists
Q91646371The Epac1 Protein: Pharmacological Modulators, Cardiac Signalosome and Pathophysiology
Q34465923The future of EPAC-targeted therapies: agonism versus antagonism
Q38934306The role of Epac in the heart.

Search more.